Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P1736-05 placebo-controlled phase II study in adults with type 2 diabetes mellitus
2009-016382-29Phase 2Completed
- Sponsor
- Piramal Phytocare
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing P1736-05 with Placebo (2 arms). Primary endpoints: Change in fasting plasma glucose versus baseline after 12 weeks, Change in fasting plasma insulin and 8 more. Started Oct 2009; status: completed.
02
Drugs
P1736-05
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-016382-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016382-29.